By Adolfo Pesquera | March 11, 2024
Ontario, Canada-based Patent Armory Inc. added another five defendants this week to its list of dozens of U.S. companies it sued under various patent infringement claims.
By Adolfo Pesquera | March 11, 2024
Ontario, Canada-based Patent Armory Inc. added another five defendants this week to its list of dozens of U.S. companies it sued under various patent infringement claims.
By Dan Roe | March 5, 2024
A slow year for contingency collections contributed to the IP firm's 2.4% decline in gross revenue, firm president and CEO John Adkisson said.
By Adolfo Pesquera | February 28, 2024
Susman Godfrey said that in the 2016 agreement KPN gave Samsung certain rights to KPN's voluminous patent portfolio in return for future payment conditions that KPN contended Samsung was not honoring.
National Law Journal | Analysis|Commentary
By Alex Anteau | February 27, 2024
"There's no thornier issue than obviousness in patentability," said IP attorney Kevin Crosby.
By Jim Soong | February 26, 2024
Each decision involves reversal of a prior art rejection and contrasts with the other decisions on subject matter eligibility, revealing different PTAB approaches and results that can inform prosecution and appeal strategies.
By Ross Todd | February 23, 2024
Adam Alper and Michael De Vries helped Samsung fight off infringement claims from Demaray LLC at trial in Waco, Texas, marking their seventh straight trial win in high-stakes cases.
By Leanne Rakers and Caley McCarthy | February 21, 2024
The future of antibody claiming in the United States is uncertain following the U.S. Supreme Court's ruling in 'Amgen Inc. v. Sanofi,' a highly anticipated decision concerning enablement and whether the traditional way to claim antibodies — claiming antibodies by their function — will survive as a valid claiming strategy.
By Lionel Lavenue, Joseph Myles and Michael Nielsen, Finnegan | February 20, 2024
When determining appropriate source code review location for internationally stored source code, courts must balance convenience, security, and efficiency of review.
The Legal Intelligencer | News
By Amanda O'Brien | February 16, 2024
Duke Fitch started at the company as a medicinal chemist and rose to vice president of U.S. pharmaceutical patents after earning his law degree.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS